Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
14.20
0.00 (0.00%)
At close: Jun 18, 2026, 4:00 PM EDT
14.01
-0.19 (-1.37%)
After-hours: Jun 18, 2026, 7:15 PM EDT
Immunic Market Cap
Immunic has a market cap or net worth of $193.43 million as of June 18, 2026. Its market cap has increased by 160.48% in one year.
Market Cap
193.43M
Enterprise Value
7.22M
1-Year Change
160.48%
Ranking
Category
Stock Price
$14.20
Market Cap Chart
Since April 15, 2019, Immunic's market cap has decreased from $243.61M to $193.43M, a decrease of -20.60%. That is a compound annual growth rate of -3.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 193.43M | 201.31% |
| Dec 31, 2025 | 64.20M | -28.73% |
| Dec 31, 2024 | 90.08M | 33.02% |
| Dec 29, 2023 | 67.72M | 9.04% |
| Dec 30, 2022 | 62.10M | -75.28% |
| Dec 31, 2021 | 251.21M | -20.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Karyopharm Therapeutics | 204.42M |
| Q32 Bio | 201.78M |
| ProQR Therapeutics | 199.14M |
| Alector | 194.29M |
| Equillium | 192.84M |
| LENZ Therapeutics | 192.83M |
| Tonix Pharmaceuticals Holding | 191.45M |
| Outlook Therapeutics | 190.96M |